Synchronoss Technologies, Inc. Announces Second Quarter Results
Lurie added, “We believe we will begin delivering substantial improvements in our financial results in the second half of 2018. We currently expect revenue to grow sequentially in the second half of the year and that we will generate adjusted EBITDA profitability and positive free cash flow for the second half. We are confident that we are positioned to return to a financial profile characterized by significant top-line growth and substantial profitability over time.”
Financial Highlights for the Second Quarter of 2018
GAAP
- Total Revenue:
$76.7 million compared to$119.0 million in the second quarter of 2017. - Gross profit:
$37.2 million compared to$71.2 million in the second quarter of 2017. - Operating Loss: (
$43.1 million ) compared to ($8.9 million ) in the second quarter of 2017. - Net Loss attributable to
Synchronoss : ($47.3 million ) compared to ($26.6 million ) in the second quarter of 2017. - Loss per Diluted Share:
($1.20) compared to($0.60) in the second quarter of 2017.
Non-GAAP
- Gross profit:
$38.5 million compared to$72.2 million in the second quarter of 2017. - Operating Income/Loss: (
$15.0 million ) compared to$18.4 million in the second quarter of 2017. - Adjusted EBITDA:
$0.0 million compared to$33.5 million in the second quarter of 2017. - Net Income/Loss attributable to
Synchronoss : ($19.0 million ) compared to$10.7 million in the second quarter of 2017. - Earnings/Loss per Diluted Share:
($0.48) compared to$0.24 in the second quarter of 2017.
A reconciliation of GAAP to non-GAAP results has been provided in the financial statement tables included in this press release. An explanation of these measures is also included below under the heading "Non-GAAP Financial Measures."
Conference Call Details
In conjunction with this announcement, Synchronoss will host a conference call on Thursday, August 9, 2018, at 4:30 p.m. (ET) to discuss the company’s financial results. To access this call, dial 877-407-9208 (domestic) or 201-493-6784 (international). The pass code for the call is 13681828. Additionally, a live web cast of the conference call will be available on the “Investor Relations” page on the company’s web site.
Following the conference call, a replay will be available for a limited time at 844-512-2921 (domestic) or 412-317-6671 (international). The replay pass code is 13681828. An archived web cast of this conference call will also be available on the “Investor Relations” page of the company’s web site, www.synchronoss.com.
Non-GAAP Financial Measures
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures as detailed above. As previously mentioned, a reconciliation of GAAP to non-GAAP results has been provided in the financial statement tables included in this press release.
About
Forward-looking Statements
This press release includes statements concerning
SYNCHRONOSS TECHNOLOGIES, INC. | ||||
CONSOLIDATED BALANCE SHEETS | ||||
(In thousands) | ||||
(Unaudited) | ||||
June 30, 2018 | December 31, 2017 | |||
ASSETS | ||||
Current assets: | ||||
Cash and cash equivalents | 222,785 | 156,299 | ||
Restricted cash | 3,480 | 89,826 | ||
Marketable securities | 5,411 | 3,111 | ||
Accounts receivable, net of allowances of $3,992 and $3,107 at June 30, 2018 and December 31, 2017, respectively | 51,439 | 78,186 | ||
Prepaid expenses and other current assets | 57,387 | 43,557 | ||
Total current assets | 340,502 | 370,979 | ||
Marketable securities | 9,021 | - | ||
Property and equipment, net | 89,310 | 111,825 | ||
Goodwill | 233,298 | 237,303 | ||
Intangible assets, net | 128,164 | 132,167 | ||
Other assets | 13,090 | 5,236 | ||
Note receivable from related party | 84,314 | 73,984 | ||
Equity method investment | 30,412 | 33,917 | ||
Total assets | 928,111 | 965,411 | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
Current liabilities: | ||||
Accounts payable | 13,924 | 5,959 | ||
Accrued expenses | 54,540 | 72,739 | ||
Deferred revenues, current | 31,391 | 75,829 | ||
Mandatorily redeemable financial instrument | - | 37,959 | ||
Total current liabilities | 99,855 | 192,486 | ||
Lease financing obligation | 10,319 | 11,183 | ||
Convertible debt, net of debt issuance costs | 228,410 | 227,704 | ||
Deferred tax liabilities | 12,472 | 13,735 | ||
Deferred revenues, non-current | 39,475 | 25,241 | ||
Other liabilities | 15,390 | 6,195 | ||
Redeemable noncontrolling interest | 12,500 | 25,280 | ||
Commitments and contingencies (Note 12) | ||||
Series A Convertible Participating Perpetual Preferred Stock,
$0.0001 par value; 10,000 shares authorized; 188 shares issued and |
168,945 | - | ||
Stockholders’ equity: | ||||
Common stock, $0.0001 par value; 100,000 shares authorized, 49,439
and 52,024 shares issued; 42,277 and 46,965 outstanding |
5 | 5 | ||
Treasury stock, at cost (7,162 and 5,059 shares at June 30, 2018 and December 31, 2017, respectively) | (82,084) | (105,584) | ||
Additional paid-in capital | 554,218 | 597,553 | ||
Accumulated other comprehensive loss | (28,938) | (23,373) | ||
Accumulated deficit | (102,456) | (5,014) | ||
Total stockholders’ equity | 340,745 | 463,587 | ||
Total liabilities and stockholders’ equity | 928,111 | 965,411 | ||
SYNCHRONOSS TECHNOLOGIES, INC. | ||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||
(In thousands, except per share data) | ||||
(Unaudited) | ||||
Three Months Ended June 30, | ||||
2018 | 2017 | |||
Net revenues | 76,742 | 118,990 | ||
Costs and expenses: | ||||
Cost of revenues | 39,525 | 47,755 | ||
Research and development | 20,200 | 20,819 | ||
Selling, general and administrative | 33,938 | 29,353 | ||
Restructuring charges | 2,778 | 6,405 | ||
Depreciation and amortization | 23,401 | 23,552 | ||
Total costs and expenses | 119,842 | 127,884 | ||
Loss from continuing operations | (43,100) | (8,894) | ||
Interest income | 3,763 | 3,026 | ||
Interest expense | (1,318) | (11,844) | ||
Other expense, net | (23) | (1,556) | ||
Equity method investment (Loss) Income | (7) | 233 | ||
Loss from continuing operations, before taxes | (40,685) | (19,035) | ||
(Provision) benefit for income taxes | (579) | (3,573) | ||
Net loss from continuing operations | (41,264) | (22,608) | ||
Net loss from discontinued operations, net of tax | - | (6,775) | ||
Net loss | (41,264) | (29,383) | ||
Net loss attributable to redeemable noncontrolling interests | 1,259 | 2,815 | ||
Preferred stock dividend | (7,260) | - | ||
Net loss attributable to Synchronoss | (47,265) | (26,568) | ||
Basic: | ||||
Continuing operations | (1.20) | (0.44) | ||
Discontinued operations | - | (0.16) | ||
(1.20) | (0.60) | |||
Diluted: | ||||
Continuing operations | (1.20) | (0.44) | ||
Discontinued operations | - | (0.16) | ||
(1.20) | (0.60) | |||
Weighted-average common shares outstanding: | ||||
Basic | 39,456 | 44,618 | ||
Diluted | 39,456 | 44,618 | ||
SYNCHRONOSS TECHNOLOGIES, INC. | ||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||
(In thousands) | ||||
(Unaudited) | ||||
Six Months Ended June 30, | ||||
2018 | 2017 | |||
Operating activities: | ||||
Net loss from continuing operations | (79,241) | (68,060) | ||
Net loss from discontinued operations | - | (22,909) | ||
Adjustments to reconcile Net Loss to net cash used in operating activities: | ||||
Depreciation and amortization expense | 46,672 | 47,639 | ||
Change in fair value of financial instruments | (3,849) | - | ||
Amortization of debt issuance costs | 706 | 3,147 | ||
Accrued PIK interest | (7,037) | (5,643) | ||
Loss (earnings) from equity method investments | 212 | (981) | ||
Gain on disposals | - | (4,947) | ||
Discontinued operations non-cash and working capital adjustments | - | 59,278 | ||
Amortization of bond premium | 44 | 177 | ||
Deferred income taxes | (1,223) | (13,304) | ||
Non-cash interest on leased facility | 547 | 533 | ||
Stock-based compensation | 14,824 | 10,749 | ||
Changes in operating assets and liabilities: | ||||
Accounts receivable, net of allowance for doubtful accounts | 29,334 | 623 | ||
Prepaid expenses and other current assets | (13,415) | (14,869) | ||
Other assets | 1,260 | 2,351 | ||
Accounts payable | 8,109 | (9,847) | ||
Accrued expenses | (24,685) | (18,746) | ||
Other liabilities | 632 | (31) | ||
Lease obligation interest payment | (483) | - | ||
Deferred revenues | (43,788) | 14,539 | ||
Net cash used in operating activities | (71,381) | (20,301) | ||
Investing activities: | ||||
Purchases of fixed assets | (3,820) | (5,235) | ||
Purchases of intangible assets and capitalized software | (8,201) | (5,300) | ||
Proceeds from the sale of SpeechCycle | - | 13,500 | ||
Purchases of marketable securities available for sale | (13,383) | (219) | ||
Maturity of marketable securities available for sale | 1,970 | 7,191 | ||
Equity investment | - | 608 | ||
Investing in discontinued operations | - | (7,213) | ||
Investment in note receivable | - | (6,187) | ||
Business acquired, net of cash | (9,798) | (815,008) | ||
Net cash used in investing activities | (33,232) | (817,863) | ||
Financing activities: | ||||
Share-based compensation-related proceeds, net of taxes paid on withholding shares | - | 2,460 | ||
Debt issuance costs related to the Credit Facility | - | (3,692) | ||
Debt issuance costs related to long term debt | - | (19,887) | ||
Proceeds from issuance of long term debt | - | 900,000 | ||
Repayment of long term debt | - | (2,250) | ||
Repayment of revolving line of credit | - | (29,000) | ||
Proceeds from the sale of treasury stock in connection with an employee stock purchase plan | - | 1,047 | ||
Proceeds from issuance of preferred stock | 86,220 | - | ||
Payments on capital obligations | (718) | (1,359) | ||
Net cash provided by financing activities | 85,502 | 847,319 | ||
Effect of exchange rate changes on cash | (749) | 2,550 | ||
Net decrease in cash, restricted cash and cash equivalents | (19,860) | 11,705 | ||
Cash, restricted cash and cash equivalents, beginning of period | 246,125 | 211,433 | ||
Cash, restricted cash and cash equivalents, end of period | 226,265 | 223,138 | ||
Supplemental disclosures of non-cash investing and financing activities: | ||||
Issuance of common stock in connection with Intralinks acquisition | - | 4,700 | ||
Cash and cash equivalents per the Consolidated Balance Sheets | 222,785 | 216,558 | ||
Restricted cash per the Consolidated Balance Sheets | 3,480 | 6,580 | ||
Total cash, cash equivalents and restricted cash | 226,265 | 223,138 | ||
SYNCHRONOSS TECHNOLOGIES, INC. | ||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES | ||||
(in thousands, except per share data) | ||||
(Unaudited) | ||||
Three Months |
Three Months |
|||
2018 | 2017 | |||
Non-GAAP financial measures and reconciliation: |
||||
GAAP Revenue | 76,742 | 118,990 | ||
Less: Cost of revenues | 39,525 | 47,755 | ||
GAAP Gross Profit | 37,217 | 71,235 | ||
Add: Stock-based compensation expense | 1,300 | 471 | ||
Add: Acquisition costs | - | - | ||
Add: Integration |
- | 501 | ||
Non-GAAP Gross Profit | 38,517 | 72,207 | ||
Non-GAAP Gross Margin | 50% | 61% | ||
GAAP (loss) income from continuing operations | (43,100) | (8,894) | ||
Add: Stock-based compensation expense | 7,638 | 2,638 | ||
Add: Acquisition costs | (10) | 1,248 | ||
Add: Restructuring | 2,778 | 6,405 | ||
Add: Amortization expense | 8,396 | 8,449 | ||
Add: Integration | - | 2,756 | ||
Add: One-Time Expenses due to Restatement, etc. | 9,305 | 5,839 | ||
Non-GAAP loss from continuing operations | (14,993) | 18,441 | ||
GAAP Net (loss) income attributable to Synchronoss | (47,265) | (26,568) | ||
Add: Net loss from discontinued operations, net of taxes | - | (6,775) | ||
Net (loss) income from continuing operations attributable to Synchronoss | (47,265) | (19,793) | ||
Add: Stock-based compensation expense | 7,638 | 2,638 | ||
Add: Acquisition costs | (10) | 1,248 | ||
Add: Restructuring | 2,778 | 6,405 | ||
Add: Amortization expense | 8,396 | 8,449 | ||
Less: Non-GAAP Expenses attributable to Non-Controlling Interest | (373) | (406) | ||
Add: One-Time Expenses due to Restatement, etc. | 9,305 | 5,839 | ||
Add: Integration | - | 2,756 | ||
Less: Income Tax Effect at Statutory Tax Rates |
579 | 3,573 | ||
Non-GAAP net (loss) income from continuing operations attributable to Synchronoss | (18,952) | 10,709 | ||
Diluted Non-GAAP net (loss) income from continuing operations per share | (0.48) | 0.24 | ||
Weighted shares outstanding - Basic | 39,456 | 44,618 | ||
SYNCHRONOSS TECHNOLOGIES, INC. | ||||
Consolidated Statement of Cash Flows | ||||
NON-GAAP Reconciliation | ||||
(in Thousands) | ||||
(Unaudited) | ||||
Six Months Ended |
Six Months Ended |
|||
2018 | 2017 | |||
Net Cash (used in) provided by operating activities | (71,381) | (20,301) | ||
Add: SW Capitalization | 8,201 | 5,300 | ||
Add: Fixed Assets | 3,820 | 5,235 | ||
Free Cashflow | (83,402) | (30,836) | ||
Less: One-Time Restatement Expenses | 15,970 | 5,839 | ||
Adjusted Free Cashflow | (67,432) | (24,997) | ||
SYNCHRONOSS TECHNOLOGIES, INC. | ||||
Reconciliation of GAAP to NON-GAAP Financial Measures | ||||
(in thousands, except per share data) |
||||
(Unaudited) | ||||
Three Months Ended |
Three Months Ended |
|||
2018 | 2017 | |||
GAAP Income from Operations | (43,100) | (8,894) | ||
Add: Stock based compensation | 7,638 | 2,638 | ||
Add: Acquisition, Restructuring & Integration | 2,768 | 10,409 | ||
Add: Depreciation & Amortization | 23,401 | 23,552 | ||
Add: Restatement Expenses | 9,305 | 5,839 | ||
Adjusted EBITDA | 12 | 33,544 | ||
View source version on businesswire.com: https://www.businesswire.com/news/home/20180809005748/en/
Source:
Investors:
ICR
Brian Denyeau, +1-646-277-1251
investor@synchronoss.com
or
Media:
CCGroup
US:
Diane Rose, +1 727-238-7567
International: Alex Sowden, +44
20-3824-9208
synchronoss@ccgrouppr.com